See more : Sydinvest – USA Ligevægt & Value (SYIULVADKK.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Avacta Group Plc (AVCTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avacta Group Plc, a leading company in the Biotechnology industry within the Healthcare sector.
- City Union Bank Limited (CUB.NS) Income Statement Analysis – Financial Results
- DXN Limited (DXN.AX) Income Statement Analysis – Financial Results
- 26 Capital Acquisition Corp. (ADERW) Income Statement Analysis – Financial Results
- Helius Medical Technologies, Inc. (HSM.TO) Income Statement Analysis – Financial Results
- Acom Co., Ltd. (8572.T) Income Statement Analysis – Financial Results
Avacta Group Plc (AVCTF)
About Avacta Group Plc
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.25M | 9.65M | 2.94M | 3.64M | 4.12M | 2.76M | 2.74M | 2.17M | 1.81M | 3.18M | 2.70M | 3.13M | 2.45M | 2.07M | 944.00K | 466.00K | 212.00K | 4.00K | 313.00K | 19.00K | 0.00 | 11.00K | 9.00K |
| Cost of Revenue | 15.67M | 2.41M | 924.00K | 1.46M | 905.00K | 893.00K | 941.00K | 895.00K | 526.00K | 1.14M | 1.19M | 1.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 224.00K | 38.00K | 0.00 | 7.00K | 2.00K |
| Gross Profit | 7.57M | 7.24M | 2.02M | 2.18M | 3.22M | 1.87M | 1.79M | 1.27M | 1.29M | 2.04M | 1.51M | 1.51M | 2.45M | 2.07M | 944.00K | 466.00K | 212.00K | 3.00K | 89.00K | -19.00K | 0.00 | 4.00K | 7.00K |
| Gross Profit Ratio | 32.58% | 75.03% | 68.58% | 59.98% | 78.05% | 67.68% | 65.59% | 58.66% | 70.99% | 64.12% | 56.04% | 48.27% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 75.00% | 28.43% | -100.00% | 0.00% | 36.36% | 77.78% |
| Research & Development | 14.53M | 11.10M | 13.48M | 8.96M | 5.94M | 3.78M | 2.60M | 1.50M | 0.00 | 0.00 | 0.00 | 0.00 | 192.00K | 161.00K | 858.00K | 862.00K | 0.00 | 0.00 | 0.00 | 30.00K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.91M | 2.29M | 0.00 | 0.00 | 8.47M | 8.52M | 7.18M | 5.43M | 6.85M | 4.11M | 3.39M | 3.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 61.00K | 94.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 16.86M | 11.23M | 8.14M | 7.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 20.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 19.76M | 13.52M | 8.14M | 7.32M | 8.47M | 8.52M | 7.18M | 5.43M | 6.85M | 4.11M | 3.39M | 3.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.00K | 114.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 34.29M | 35.06M | 31.10M | 21.52M | 14.40M | 12.30M | 9.78M | 6.93M | 6.85M | 4.11M | 3.39M | 3.15M | 3.61M | 3.73M | 2.90M | 2.12M | 1.40M | 137.00K | 308.00K | 362.00K | 100.00K | 164.00K | 156.00K |
| Cost & Expenses | 49.96M | 37.47M | 32.02M | 22.97M | 15.31M | 13.19M | 10.72M | 7.83M | 7.38M | 5.25M | 4.57M | 4.77M | 3.61M | 3.73M | 2.90M | 2.12M | 1.40M | 137.00K | 532.00K | 362.00K | 100.00K | 171.00K | 158.00K |
| Interest Income | 655.00K | 91.00K | 17.00K | 43.00K | 51.00K | 41.00K | 88.00K | 99.00K | 26.00K | 24.00K | 21.00K | 39.00K | 4.00K | 0.00 | 25.00K | 83.00K | 53.00K | 1.00K | 2.00K | 6.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.73M | 2.70M | 128.00K | 93.00K | 69.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 2.00K | 3.00K | 4.00K | 2.00K | 0.00 | 4.00K | 6.00K | 11.00K | 6.00K | 1.00K |
| Depreciation & Amortization | 3.67M | 3.01M | 2.38M | 2.15M | 2.10M | 2.86M | 1.58M | 1.25M | 2.98M | 527.00K | 367.00K | 238.00K | 246.00K | 209.00K | 96.00K | 57.00K | 20.00K | -265.00K | 67.00K | 82.00K | 25.00K | 41.00K | 51.00K |
| EBITDA | -23.05M | -25.87M | -26.69M | -17.36M | -9.08M | -7.58M | -6.40M | -4.42M | -2.58M | -1.54M | -1.51M | -1.37M | -915.00K | -1.45M | -1.83M | -1.51M | -1.11M | -132.00K | -183.00K | -255.00K | -75.00K | -119.00K | -98.00K |
| EBITDA Ratio | -99.14% | -267.99% | -907.51% | -477.31% | -220.25% | -274.16% | -233.93% | -204.06% | -142.53% | -48.43% | -55.78% | -43.61% | -37.42% | -70.15% | -193.96% | -324.55% | -525.47% | -3,300.00% | -58.47% | -1,342.11% | 0.00% | -1,081.82% | -1,088.89% |
| Operating Income | -26.72M | -32.65M | -29.08M | -21.29M | -11.18M | -10.43M | -7.98M | -5.66M | -5.57M | -2.07M | -1.87M | 1.64M | 1.13M | 2.03M | 2.86M | 1.65M | -1.13M | 133.00K | 252.00K | 343.00K | -100.00K | 160.00K | 149.00K |
| Operating Income Ratio | -114.93% | -338.19% | -988.88% | -585.62% | -271.23% | -377.52% | -291.81% | -261.62% | -307.06% | -65.00% | -69.37% | 52.46% | 46.01% | 98.02% | 302.65% | 354.59% | -534.91% | 3,325.00% | 80.51% | 1,805.26% | 0.00% | 1,454.55% | 1,655.56% |
| Total Other Income/Expenses | 247.00K | -9.00M | -111.00K | -50.00K | 51.00K | 41.00K | 88.00K | 99.00K | 26.00K | 24.00K | 21.00K | -3.25M | -2.25M | -4.05M | -5.69M | -3.23M | -85.00K | -240.00K | -1.31M | -686.00K | -11.00K | -326.00K | -299.00K |
| Income Before Tax | -26.47M | -41.64M | -29.19M | -21.34M | -11.13M | -10.39M | -7.89M | -5.57M | -5.54M | -2.04M | -1.85M | -1.60M | -1.12M | -2.03M | -2.84M | -1.57M | -1.22M | -107.00K | -1.06M | -343.00K | -111.00K | -166.00K | -150.00K |
| Income Before Tax Ratio | -113.86% | -431.39% | -992.66% | -586.99% | -270.00% | -376.04% | -288.59% | -257.04% | -305.63% | -64.25% | -68.59% | -51.21% | -45.89% | -98.11% | -300.32% | -337.64% | -575.00% | -2,675.00% | -338.02% | -1,805.26% | 0.00% | -1,509.09% | -1,666.67% |
| Income Tax Expense | -2.37M | -2.10M | -2.82M | -2.45M | -1.45M | -1.56M | -1.53M | -918.00K | -648.00K | -551.00K | -331.00K | -497.00K | -531.00K | -149.00K | -150.00K | -105.00K | 0.00 | 0.00 | 45.00K | -45.00K | 0.00 | -320.00K | -298.00K |
| Net Income | -24.95M | -39.19M | -26.32M | -18.89M | -9.68M | -8.83M | -6.37M | -4.65M | -9.99M | -1.49M | -1.52M | -1.11M | -591.00K | -1.88M | -2.69M | -1.47M | -1.22M | -107.00K | -1.10M | -298.00K | -111.00K | -166.00K | -150.00K |
| Net Income Ratio | -107.31% | -405.98% | -894.80% | -519.55% | -234.85% | -319.54% | -232.80% | -214.64% | -551.08% | -46.92% | -56.33% | -35.34% | -24.17% | -90.90% | -284.43% | -315.11% | -575.00% | -2,675.00% | -352.40% | -1,568.42% | 0.00% | -1,509.09% | -1,666.67% |
| EPS | -0.09 | -0.15 | -0.11 | -0.08 | -0.08 | -0.13 | -0.10 | -0.07 | -0.20 | -0.04 | -0.05 | -0.04 | -0.04 | -0.15 | -0.28 | -0.18 | -0.18 | 0.00 | -1.22 | -0.44 | -0.12 | -0.18 | -0.17 |
| EPS Diluted | -0.09 | -0.15 | -0.11 | -0.08 | -0.08 | -0.13 | -0.10 | -0.07 | -0.20 | -0.04 | -0.05 | -0.04 | -0.04 | -0.15 | -0.28 | -0.18 | -0.18 | 0.00 | -1.22 | -0.44 | -0.12 | -0.18 | -0.17 |
| Weighted Avg Shares Out | 272.68M | 255.37M | 249.56M | 225.65M | 120.38M | 65.46M | 65.18M | 67.74M | 49.75M | 41.83M | 31.58M | 25.00M | 15.49M | 12.61M | 9.50M | 8.02M | 6.93M | 33.48M | 903.65K | 679.47K | 900.00K | 900.00K | 900.00K |
| Weighted Avg Shares Out (Dil) | 272.68M | 255.37M | 249.56M | 225.65M | 120.38M | 65.46M | 65.18M | 67.74M | 49.75M | 41.83M | 31.58M | 25.00M | 15.49M | 12.61M | 9.50M | 8.02M | 6.93M | 33.48M | 903.65K | 679.47K | 900.00K | 900.00K | 900.00K |
Avacta Group Plc (AVCTF) Q2 2024 Earnings Call Transcript
Avacta Group PLC (AVCTF) Q4 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports